RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 Adalimumab Therapy is Effective and Well Tolerated in AS, RA, and PsA Patients with a History of Insufficient Response or Intolerance to Other Anti—TNF Therapies
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 5
SP 21
OP 22
DO 10.1177/155989770800800513
UL http://mdc.sagepub.com/content/8/5/21.abstract
AB This article discusses data from RHAPSODY [NCT00478660; AS], ReAct [NCT00650026; RA], and STEREO [NCT00235885; PsA] - 3 open-label trials that examined the effectiveness of adalimumab treatment in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriatic arthritis who had a history of anti-TNF therapy.